INTERACTIVE FIRESIDE CHAT: How to be GMP-GCP compliant while optimizing resources, quality processes, and regulatory alignment

  • How to plan and allocate resources effectively across the full study lifecycle (from manufacturing to release and distribution)
  • How to prepare for audits and inspections proactively incorporating audit readiness into daily workflows to avoid last minute firefighting
  • The value of leveraging external partners and CDMOs effectively to improve quality oversight with limited internal teams

 

INTERACTIVE BOARDROOM: COLLABORATE, SOLVE, SHARE 🤝

AI is powerful, but the drug and the patient come first. This boardroom explores how teams can leverage AI safely, integrate it into workflows, and maintain human control with strong processes.

Shift from “random prompting” to building Structured Supply Chain AI Workflows that save hours while keeping human oversight and data security intact

Outcome: Each table will collaborate to create practical strategies, and governance approaches that balance AI capabilities with human oversight, ensuring AI enhances decisions rather than replacing critical thinking.

 

ASK THE EXPERT PANEL: How to choose CDMOs as a true extension of your team to enable flexible, and stage-specific clinical supply needs 📊 LIVE POLL

  • How to align CDMO partnerships with phase-specific needs while staying agile
  • How to collaborate across CDMOs and ensure smooth tech transitions, especially for biologics therapies
  • How to build transparent CDMO partnerships from Day 1 to overcome challenges and save costs

Moderator: Amanda Murphy, Head of Digital Product Management, GlobalData

  • Panelist 1: Aimee Hogue, Director Supply Chain, Sutro Biopharma
  • Panelist 2: Amber Bill, Associate Director, Sangamo Therapeutics  

Panelist 3: Burkard Kolb, Former Executive Director, CMC Operations, 89bio  (Genentech)